Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe?

To reduce long-term morbidity after revascularised acute myocardial infarction, different therapeutic strategies have been investigated. Cell therapy with mononuclear cells from bone marrow (BMMC) or peripheral blood (PBMC) has been proposed to attenuate the adverse processes of remodelling and subs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robbers, L. F. H. J., Nijveldt, R., Beek, A. M., Kemme, M. J. B., Delewi, R., Hirsch, A., van der Laan, A. M., van der Vleuten, P. A., Piek, J. J., Zijlstra, F., van Rossum, A. C.
Formato: Artigo
Lenguaje:Inglês
Publicado: Bohn Stafleu van Loghum 2012
Materias:
ICIN
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286504/
https://ncbi.nlm.nih.gov/pubmed/22351557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-012-0251-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares